Literature DB >> 10995524

Hypertension in the HIV-infected patient.

S Aoun1, E Ramos.   

Abstract

HIV infection has reached endemic proportions in many African countries. In addition, HIV infection is a significant cause of renal dysfunction in the United States. HIV patients are at higher risk of developing hypertension at a younger age than the general population. Predisposing factors for developing hypertension include vasculitis in small, medium, and large vessels in the form of leukocytoclastic vasculitis, and aneurysms of the large vessels such as the carotid, femoral, and abdominal aorta with impairment of flow to the renal arteries. A syndrome of acquired glucocorticoid resistance has been described in patients with HIV with hypercortisolism and a lower affinity of the glucocorticoid receptors. The syndrome is characterized clinically by weakness, hypertension or hypotension, and skin pigmentation changes. Acute and chronic renal failure is often associated with HIV infection. The associated dysfunction in water and salt handling often induces hypertension. Finally, atherosclerosis has been described in young adults with HIV infection secondary to receiving highly active antiretroviral therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10995524     DOI: 10.1007/s11906-000-0031-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  35 in total

1.  Prolonged clinical improvement in HIV-associated nephropathy with zidovudine therapy.

Authors:  P P Cook; R G Appel
Journal:  J Am Soc Nephrol       Date:  1990-11       Impact factor: 10.121

2.  Large artery vasculopathy in HIV-positive patients: another vasculitic enigma.

Authors:  R Chetty; S Batitang; R Nair
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

Review 3.  Human immunodeficiency virus (HIV) infection and the kidney.

Authors:  R J Glassock; A H Cohen; G Danovitch; K P Parsa
Journal:  Ann Intern Med       Date:  1990-01-01       Impact factor: 25.391

4.  The haemolytic uraemic syndrome in patients with AIDS.

Authors:  P Kelleher; A Severn; C Tomson; S Lucas; J Parkin; A Pinching; R Miller
Journal:  Genitourin Med       Date:  1996-06

5.  Coronary artery lesions and human immunodeficiency virus infection.

Authors:  P Paton; A Tabib; R Loire; R Tete
Journal:  Res Virol       Date:  1993 May-Jun

Review 6.  Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy.

Authors:  M C Smith; R Pawar; J T Carey; R C Graham; G H Jacobs; A Menon; R A Salata; R Seliga; R C Kalayjian
Journal:  Am J Med       Date:  1994-08       Impact factor: 4.965

7.  Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: a case report.

Authors:  G C Burns; R Matute; D Onyema; I Davis; I Toth
Journal:  Am J Kidney Dis       Date:  1994-03       Impact factor: 8.860

8.  Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy.

Authors:  E S Cantor; P L Kimmel; J P Bosch
Journal:  Arch Intern Med       Date:  1991-01

9.  Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study.

Authors:  V D'Agati; J I Suh; L Carbone; J T Cheng; G Appel
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

Review 10.  The syndrome of acquired glucocorticoid resistance in HIV infection.

Authors:  G Norbiato; M Galli; V Righini; M Moroni
Journal:  Baillieres Clin Endocrinol Metab       Date:  1994-10
View more
  18 in total

Review 1.  Cardiovascular manifestations of HIV infection.

Authors:  G Barbaro
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

Review 2.  Plant glutaredoxins: still mysterious reducing systems.

Authors:  N Rouhier; E Gelhaye; J-P Jacquot
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

3.  [Coronary artery disease in HIV-infected subjects. Results of 101 coronary angiographies].

Authors:  T Neumann; K A Lülsdorf; P Krings; N Reinsch; R Erbel
Journal:  Herz       Date:  2010-12-23       Impact factor: 1.443

4.  Myocardial and Pericardial Disease in HIV.

Authors:  William G. Harmon; Gul H. Dadlani; Stacy D. Fisher; Steven E. Lipshultz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-12

Review 5.  Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.

Authors:  Bente Magny Bergersen
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  Rapid progression of atherosclerotic coronary artery disease in patients with human immunodeficiency virus infection.

Authors:  Lukas E Spieker; Bilgehan Karadag; Christian Binggeli; Roberto Corti
Journal:  Heart Vessels       Date:  2005-07       Impact factor: 2.037

7.  The human immunodeficiency virus and the cardiometabolic syndrome in the developing world: an African perspective.

Authors:  Eugene Mutimura; Nigel J Crowther; Aimee Stewart; W Todd Cade
Journal:  J Cardiometab Syndr       Date:  2008

8.  Hypertension in treated and untreated patients with HIV: a study from 2011 to 2013 at the Jos University Teaching Hospital, Nigeria.

Authors:  Samson E Isa; Arthur R Kang'ombe; Gomerep S Simji; Nathan Y Shehu; Agbaji O Oche; John A Idoko; Luis E Cuevas; Geoffrey V Gill
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-04-01       Impact factor: 2.184

9.  Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients.

Authors:  B M Bergersen; L Sandvik; O Dunlop; K Birkeland; J N Bruun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-11       Impact factor: 3.267

10.  Factors associated with prognostic or treatment outcomes in HIV/AIDS patients with and without hypertension in Eswatini.

Authors:  Sabelo Bonginkosi Dlamini; Hans-Uwe Dahms; Ming-Tsang Wu
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.